Scinovex
article Open AccessTop 1% cited

XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study

Diabetes Care · 2004 · Vol. 27(1) · pp. 155–161
Jarl TorgersonJonathan HauptmanMark BoldrinLars Sjöström

Abstract

Compared with lifestyle changes alone, orlistat plus lifestyle changes resulted in a greater reduction in the incidence of type 2 diabetes over 4 years and produced greater weight loss in a clinically representative obese population. Difference in diabetes incidence was detectable only in the IGT subgroup; weight loss was similar in subjects with IGT or NGT [correction].

Pharmacology and Obesity TreatmentDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerOrlistatMedicineOverweightPlaceboDiabetes mellitusInternal medicineImpaired glucose toleranceType 2 diabetesWeight lossIncidence (geometry)

MeSH terms

OrlistatAdultEnergy IntakeDiabetes MellitusDouble-Blind MethodFemaleGlucose Tolerance TestHumansLactonesLife StyleLipaseMaleMiddle AgedObesityPlacebos
Citations
1,885
FWCI
98.89
field-weighted impact
References
23
Percentile
100%
vs. same field & year
Citations per year
Cited by
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.